IRIS
SARAO, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.762
AS - Asia 2.461
EU - Europa 1.254
SA - Sud America 474
Continente sconosciuto - Info sul continente non disponibili 308
AF - Africa 54
OC - Oceania 8
Totale 9.321
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.673
SG - Singapore 1.204
CN - Cina 461
BR - Brasile 385
IT - Italia 324
HK - Hong Kong 231
VN - Vietnam 208
UA - Ucraina 174
DE - Germania 149
RU - Federazione Russa 138
BD - Bangladesh 115
FR - Francia 111
IE - Irlanda 72
FI - Finlandia 70
GB - Regno Unito 65
IN - India 53
TR - Turchia 50
CA - Canada 47
AR - Argentina 36
SE - Svezia 32
NL - Olanda 25
IQ - Iraq 21
AT - Austria 20
PL - Polonia 19
KR - Corea 18
MX - Messico 18
JP - Giappone 17
BE - Belgio 15
EC - Ecuador 14
ZA - Sudafrica 13
ID - Indonesia 12
PK - Pakistan 12
CO - Colombia 9
UZ - Uzbekistan 9
PY - Paraguay 8
SA - Arabia Saudita 8
ES - Italia 7
CL - Cile 6
KE - Kenya 6
MA - Marocco 6
AU - Australia 5
EG - Egitto 5
HN - Honduras 5
PE - Perù 5
TG - Togo 5
TN - Tunisia 5
VE - Venezuela 5
CH - Svizzera 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
JO - Giordania 4
LT - Lituania 4
OM - Oman 4
PH - Filippine 4
PS - Palestinian Territory 4
PT - Portogallo 4
AZ - Azerbaigian 3
BO - Bolivia 3
JM - Giamaica 3
KZ - Kazakistan 3
RO - Romania 3
AL - Albania 2
BB - Barbados 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CY - Cipro 2
DZ - Algeria 2
EU - Europa 2
HU - Ungheria 2
IL - Israele 2
IS - Islanda 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MY - Malesia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BF - Burkina Faso 1
BJ - Benin 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GL - Groenlandia 1
GY - Guiana 1
KH - Cambogia 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
ML - Mali 1
MT - Malta 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
Totale 9.003
Salva come PNG Salva come JPEG
Città #
Ashburn 516
Singapore 494
Fairfield 428
Woodbridge 379
Chandler 360
Ann Arbor 283
Houston 249
Beijing 234
Hong Kong 226
San Jose 184
Seattle 172
Wilmington 158
Cambridge 132
Boardman 117
Council Bluffs 109
Jacksonville 95
Lauterbourg 83
Dearborn 75
Los Angeles 73
Dublin 72
Princeton 72
Ho Chi Minh City 60
New York 57
Dallas 45
Izmir 45
Hanoi 40
Buffalo 39
Udine 37
Santa Clara 36
Redondo Beach 35
Munich 27
São Paulo 27
Milan 26
Ogden 26
San Diego 25
Norwalk 23
Dong Ket 22
Helsinki 22
Frankfurt am Main 21
Chicago 18
Hefei 18
Warsaw 18
Seoul 17
The Dalles 17
Orem 16
Des Moines 15
Phoenix 15
Brussels 14
Toronto 14
Belluno 13
Rome 13
Brooklyn 12
Düsseldorf 12
Mumbai 12
Stockholm 12
Belo Horizonte 11
Denver 11
Montreal 11
Porto Alegre 11
Rio de Janeiro 11
Wuhan 11
Amsterdam 10
Bologna 10
Shenzhen 10
Vienna 10
Falls Church 9
Manchester 9
Naples 9
Tokyo 9
Atlanta 8
Da Nang 8
Lappeenranta 8
Nuremberg 8
Ottawa 8
Redmond 8
Tashkent 8
Treviso 8
Baghdad 7
Guangzhou 7
Mexico City 7
Nanjing 7
Paese 7
Shanghai 7
Turin 7
Boston 6
Brasília 6
Chengdu 6
Curitiba 6
Hangzhou 6
Johannesburg 6
Quito 6
San Francisco 6
Bắc Ninh 5
Campinas 5
Chennai 5
Grafing 5
Hyderabad 5
Lomé 5
London 5
Nairobi 5
Totale 5.703
Salva come PNG Salva come JPEG
Nome #
Triamcinolone acetonide for the treatment of diabetic macular oedema 222
A case of CRB1-negative Coats-like retinitis pigmentosa 191
Comparison of short-wavelength blue-light autofluorescence and conventional blue-light autofluorescence in geographic atrophy 186
Intravitreal aflibercept for choroidal neovascularization due to age-related macular degeneration unresponsive to ranibizumab therapy 183
Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors 172
Neovascular age-related macular degeneration 169
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: Six-month outcomes of the UDBASA study 167
Fluocinolone acetonide for the treatment of diabetic macular edema 166
Proliferative Diabetic Retinopathy: Treatment Update 165
Dexamethasone implant in diabetic macular edema in real-life situations 163
Online optical coherence tomography during subthreshold laser irradiation 162
Optimal Keratoplasty for the Correction of Presbyopia and Hypermetropia 153
Pharmacotherapy for treatment of retinal vein occlusion. 152
One-year results of aflibercept in vascularized pigment epithelium detachment due to neovascular AMD: A prospective study 152
Author’s response 151
Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes 150
Optical coherence tomography angiography findings in diabetic retinopathy 149
New advances in retina: A report from the International Symposium on Ocular Pharmacology and Therapeutics meeting 144
Delayed rhegmatogenous retinal detachment post macular surgery - a multicentric study 141
Early Effects of Dexamethasone Implant on Macular Morphology and Visual Function in Patients with Diabetic Macular Edema 140
Update on combination therapy in wet age-related macular degeneration 136
A comparison between a white LED confocal imaging system and a conventional flash fundus camera using chromaticity analysis 131
A Propensity-Score Matching Comparison between 27-Gauge and 25-Gauge Vitrectomy Systems for the Repair of Primary Rhegmatogenous Retinal Detachment 130
Safety of 6000 intravitreal dexamethasone implants 130
Drug safety evaluation of intravitreal triamcinolone acetonide 127
Macular pucker 125
Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery 122
Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 121
The Present and Future of Optic Pathway Glioma Therapy 120
Intravitreal steroids for the treatment of retinal diseases. 120
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome 118
Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa 118
Faricimab in Neovascular AMD Complicated by Pigment Epithelium Detachment: An AI-Assisted Evaluation of Early Morphological Changes 117
Scleral fixation of a single-piece foldable acrylic IOL through a 1.80 mm corneal incision 115
Regression of diabetic macular edema after subcutaneous exenatide. 114
Surgical Management for Diabetic Macular Edema 111
Aflibercept 2 mg biosimilar (Tyalia)—real-world experience from IRAN (ATRIA study) 110
Steroids in a Combination Strategy 108
Ocular Findings in {COVID}-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye 108
Anti-VEGF Drugs Dynamics: Relevance for Clinical Practice 108
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular edema: the UDBASA study 107
Green emission fluorophores in eyes with atrophic age-related macular degeneration: A colour fundus autofluorescence pilot study 101
Correction to: Fundamental principles of an effective diabetic retinopathy screening program (Acta Diabetologica, (2020), 57, 7, (785-798), 10.1007/s00592-020-01506-8) 100
TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing 99
Combination Therapy for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Anti-VEGF Monotherapy. Intravitreal Bevacizumab and Triamcinolone Acetonide 94
Automated diabetic retinopathy detection with two different retinal imaging devices using artificial intelligence: a comparison study 92
Choriocapillaris and outer choroid blood flow in acute central serous chorioretinopathy: a swept source OCT angiography study 90
Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers 85
Behind the mask: a critical perspective on the ethical, moral, and legal implications of AI in ophthalmology 84
Edema maculare post occlusione venosa 83
Biosimilar ranibizumab (BS1) – early experience from Japan (BRIJ study) 82
Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression 81
Stem cell therapy in retinal diseases: current evidence 80
Impact on quality of life 80
Early intraocular pressure dynamics following aflibercept 8 mg versus aflibercept 2 mg: a propensity score-matched analysis 78
Validation of Esaso Classification of Diabetic Maculopathy 78
Choroidal Thickness Influences Green Emission Autofluorescence Component Intensity in Eyes with Geographic Atrophy Due to Age-Related Macular degeneration: A Color Fundus Autofluorescence Study 78
Chromaticity analysis comparing a white light confocal imaging device versus a flash fundus camera 78
Fundamental principles of an effective diabetic retinopathy screening program 77
Present Status of Laser Therapy: Role of Subthreshold Laser 75
Does lens influence green component in short 450 nm color autofluorescence? A cross-sectional study in heathy Caucasian population 73
Managing diabetic macular edema in clinical practice: systematic review and meta-analysis of current strategies and treatment options 72
Enhancing Diabetic Macular Edema Treatment Outcomes: Exploring the ESASO Classification and Structural OCT Biomarkers 71
Explainable artificial intelligence model for the detection of geographic atrophy using colour retinal photographs 70
Update on coronavirus disease 2019: Ophthalmic Manifestations and Adverse Reactions to Vaccination 70
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI) 68
One-year efficacy of anti-vascular endothelial growth factor agents in patients with neovascular age-related macular degeneration: a meta-analysis and meta-regression 66
Macular Holes 64
Intravitreal Aflibercept for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Ranibizumab Therapy 62
Intravitreal Bevacizumab for Choroidal Neovascularization due to Pathological Myopia: Long-term Outcomes 62
Twelve months outcomes of Intravitreal aflibercept for neovascular age-related macular degeneration. Fixed versus as needed dosing 61
Long-term outcomes after intravitreal dexamethasone treatment in steroid responders 61
INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF DIFFUSE DIABETIC MACULAR EDEMA UNRESPONSIVE TO ANTI-VEGF THERAPY 61
Lens fogging comment on “Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy” 61
AI-assisted analysis of early fluid dynamics following aflibercept 8 mg in treatment-naïve neovascular AMD 60
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO—Is there any difference? the VITDEX study 60
The ideal intravitreal injection setting: office, ambulatory surgery room or operating theatre? A narrative review and international survey 59
Screening performance of an automated image analysis software for the detection of diabetic retinopathy using a conventional fundus photography or a confocal white LED device: a comparison study 59
Does the presence of vitreo-macular adhesion influence the outcome of antivascular endothelial growth factor therapy in patients with neovascular agerelated macular degeneration? Systematic review and meta-analysis 59
State-of-the art pharmacotherapy for non-neovascular age-related macular degeneration 58
Response to: New norms in ophthalmic surgery during the COVID-19 pandemic: A narrative review from a Malaysia tertiary eye care center 58
OCT angiography in chronic central serous chorioretinopathy 56
Long-term Effect of Intravitreal Bevacizumab on Chorioretinal Atrophy Progression in Myopic Choroidal Neovascularization 56
Ranibizumab in neovascular age-related macular degeneration: an as-needed treatment regimen with bimonthly evaluation 55
Response to: Should we establish a new normality for ophthalmic training in the COVID-19 pandemic? 55
Twelve-month treatment with intravitreal dexamethasone implant for diabetic macular edema 52
RWC Update: Different Surgical Techniques for Macular Hole Associated With Retinal Detachment; Diabetic Macular Edema – How Do You Treat Patients With Good Visual Acuity?; Benign Familial Fleck Retina 51
From pro-re-nata to fixed-interval regimen: evolving real-world treatment paradigms in anti-VEGF therapy for neovascular AMD 50
One-year outcomes of dexamethasone implant versus oral acetazolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa 45
Response to:Letter to the editor: Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 40
AI-Assisted OCT Clinical Phenotypes of Diabetic Macular Edema: A Large Cohort Clustering Study 39
Aflibercept 2 mg Biosimilar (aflibercept-ayyh, Pavblu): Experience of safety in clinical settings-APEX- safety study 26
FYB-201 Biosimilar ranibizumab (Ongavia/Ranivisio/Cimerli) Efficacy and Safety in Clinical Settings – FORCE study 24
RWC Update: Intraocular Inflammation and Retinal Pharmacotherapy; Giant Retinal Tear; ILM Peeling in Myopic Macular Schisis 14
Immediate Sequential Bilateral Cataract Surgery: Are We Overstating the Case? [Letter] 11
Comment to: Hashiya N, Maruko I, Maruko R et al. Increased intraocular pressure immediately after aflibercept 8 mg intravitreal injection for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2026) 264:1611–1617. doi:10.1007/s00417-026-07117-3 8
Switching to aflibercept 8 mg in neovascular age-related macular degeneration: real-world outcomes according to switch indication 5
Optical coherence tomography biomarkers in patients with diabetic macular edema treated with dexamethasone implants 5
Real-world effectiveness and safety of ranibizumab biosimilar FYB-201 in Saudi Arabia (Ravegza) and Jordan (Uptera): a middle eastern extension of the FORCE study 5
Totale 9.321
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.470
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022429 0 26 9 7 14 22 35 23 18 84 101 90
2022/2023758 96 51 7 121 82 179 0 71 97 4 31 19
2023/2024261 46 17 7 6 35 30 11 26 37 15 2 29
2024/20251.560 27 97 100 76 27 51 113 68 183 138 246 434
2025/20263.352 322 409 276 355 472 204 306 116 192 272 259 169
2026/2027180 174 6 0 0 0 0 0 0 0 0 0 0
Totale 9.321